These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34519330)

  • 1. Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys.
    Masilamoni GJ; Weinkle A; Papa SM; Smith Y
    Cereb Cortex; 2022 Apr; 32(9):1804-1822. PubMed ID: 34519330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.
    Villalba RM; Wichmann T; Smith Y
    Brain Struct Funct; 2014 Jan; 219(1):381-94. PubMed ID: 23508713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.
    Masilamoni GJ; Bogenpohl JW; Alagille D; Delevich K; Tamagnan G; Votaw JR; Wichmann T; Smith Y
    Brain; 2011 Jul; 134(Pt 7):2057-73. PubMed ID: 21705423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic innervation of the striatum in a nonhuman primate model of Parkinson's disease.
    Jiménez-Sánchez L; Blesa J; Del Rey NL; Monje MHG; Obeso JA; Cavada C
    Neuropharmacology; 2020 Jun; 170():107806. PubMed ID: 31589886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.
    Nayyar T; Bubser M; Ferguson MC; Neely MD; Shawn Goodwin J; Montine TJ; Deutch AY; Ansah TA
    Eur J Neurosci; 2009 Jul; 30(2):207-16. PubMed ID: 19659923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys.
    Gagnon D; Gregoire L; Di Paolo T; Parent M
    Brain Struct Funct; 2016 Sep; 221(7):3675-91. PubMed ID: 26462663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.
    Molinet-Dronda F; Blesa J; Del Rey NL; Juri C; Collantes M; Pineda-Pardo JA; Trigo-Damas I; Iglesias E; Hernández LF; Rodríguez-Rojas R; Gago B; Ecay M; Prieto E; García-Cabezas MÁ; Cavada C; Rodríguez-Oroz MC; Peñuelas I; Obeso JA
    Neurobiol Dis; 2022 Jun; 167():105669. PubMed ID: 35219857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs.
    Wade TV; Schneider JS
    J Neurosci; 2001 Jul; 21(13):4901-7. PubMed ID: 11425917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys.
    Pifl C; Hornykiewicz O
    Neurochem Int; 2006 Oct; 49(5):519-24. PubMed ID: 16698121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.
    Ballanger B; Beaudoin-Gobert M; Neumane S; Epinat J; Metereau E; Duperrier S; Broussolle E; Thobois S; Bonnefoi F; Tourvielle C; Lavenne F; Costes N; Lebars D; Zimmer L; Sgambato-Faure V; Tremblay L
    J Neurosci; 2016 Feb; 36(5):1577-89. PubMed ID: 26843639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys.
    Slovin H; Abeles M; Vaadia E; Haalman I; Prut Y; Bergman H
    J Neurophysiol; 1999 Feb; 81(2):858-74. PubMed ID: 10036286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
    Mounayar S; Boulet S; Tandé D; Jan C; Pessiglione M; Hirsch EC; Féger J; Savasta M; François C; Tremblay L
    Brain; 2007 Nov; 130(Pt 11):2898-914. PubMed ID: 17855373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
    Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
    Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.
    Kulak JM; Schneider JS
    Brain Res; 2004 Mar; 999(2):193-202. PubMed ID: 14759498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Ultrastructural Analysis of Thalamocortical Innervation of the Primary Motor Cortex and Supplementary Motor Area in Control and MPTP-Treated Parkinsonian Monkeys.
    Villalba RM; Behnke JA; Pare JF; Smith Y
    Cereb Cortex; 2021 Jun; 31(7):3408-3425. PubMed ID: 33676368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of MPTP on neurotransmission in three mouse models of Parkinson's disease.
    Pain S; Gochard A; Bodard S; Gulhan Z; Prunier-Aesch C; Chalon S
    Exp Toxicol Pathol; 2013 Jul; 65(5):689-94. PubMed ID: 23083629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.